Understanding the off-target effects of cancer drugs – and how they could lead us to new forms of treatment 03 Mar 2020 Professor Paul Workman explores how an understanding of the 'off-target' effects of drug treatments has the potential to help uncover contributions to both the beneficial action of drugs and also the unwanted side-effects. Find out more Show/Hide
‘Cure or nothing’ doesn’t capture the realities of modern cancer research and treatment 23 Dec 2019 While curing cancer will always be the ultimate goal for the ICR's researchers, Professor Paul Workman argues that it's vital we understand and accept new evolutionary approaches to treatment that can control even advanced cancers long term. Find out more Show/Hide
UK science needs a clear plan for the future 28 Jun 2019 If science in the UK is going to remain world class, it’s crucial that we have a clear plan for the future that secures research funding, ensures freedom for scientists to work across borders, and provides regulatory alignment, argues the ICR’s Chief Executive Professor Paul Workman. Find out more Show/Hide
Our manifesto for cancer drug discovery and development – focusing on innovation to tackle treatment resistance and meeting patients’ needs 30 Apr 2019
Why regulators must move with the science if we’re to get innovative new treatments to patients more quickly 05 Dec 2018